» Articles » PMID: 8798109

Determinants of Prognosis in Nonischemic Dilated Cardiomyopathy

Overview
Journal J Card Fail
Date 1996 Jun 1
PMID 8798109
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dilated cardiomyopathy, a heart muscle disease of unknown cause, is characterized by high mortality and is a major cause of cardiac transplantation. It has become, therefore, increasingly important to identify patients at higher risk. The aim of this study was to assess which of the data obtained at the time of diagnosis are the best predictors of survival.

Methods And Results: One hundred forty-four patients with dilated cardiomyopathy (118 men; mean age, 39 years) were assessed clinically, noninvasively, and hemodynamically. The effect of variables derived from the evaluation on outcome (death or heart transplantation) was examined. During a mean follow-up time of 4.1 years, 68 patients (47%) died and 9 (6%) underwent heart transplantation. The 1-, 2-, and 5-year transplant-free survival rate was 79, 69, and 44%, respectively. Cox multivariate regression analysis identified three variables as independent predictors of outcome: (1) pulmonary artery systolic pressure, P = .0001; (2) left ventricular ejection fraction, P = .0013; and (3) left ventricular end-diastolic dimension, P = .007. The prognostic index was constructed from regression coefficients and parameters significant in the Cox model. The minimal prognostic index in the study group was 1.4 and the maximal was 6.0 with a corresponding 1-year survival of 98 and 18%, respectively. The validity of the prognostic index was tested in the consecutive group of 81 patients, who were followed for a mean 2.3 years. The prognostic index of the poor outcome group differed significantly from that in survivors (3.7 vs 2.9, respectively, P < .01). The sensitivity and specificity of model predictions were 68 and 52%, respectively.

Conclusions: The severity of pulmonary hypertension and left ventricular dysfunction provides an independent insight into the prognosis of patients with dilated cardiomyopathy. The prognostic index is useful when assessing prognosis and may be helpful in the timing of heart transplantation.

Citing Articles

Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy.

Bergan N, Prachee I, Curran L, McGurk K, Lu C, de Marvao A Circulation. 2025; 151(7):442-459.

PMID: 39895490 PMC: 11827689. DOI: 10.1161/CIRCULATIONAHA.124.070872.


Anesthetic Management of Patients with Dilated Cardiomyopathy Undergoing Noncardiac Surgery.

Li M, Huang H Medicina (Kaunas). 2023; 59(9).

PMID: 37763685 PMC: 10533037. DOI: 10.3390/medicina59091567.


Clinical characteristics, etiological profile, treatment and long term outcomes in patients with non ischemic systolic heart failure; Himachal Pradesh heart failure registry (HP-HF registry).

Chand Negi P, Gupta A, Rana M, Asotra S, Ganju N, Marwah R Indian Heart J. 2023; 75(3):190-196.

PMID: 37003535 PMC: 10258369. DOI: 10.1016/j.ihj.2023.03.007.


Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy.

Jain A, Norton N, Bruno K, Cooper Jr L, Atwal P, Fairweather D J Clin Med. 2021; 10(11).

PMID: 34070351 PMC: 8197492. DOI: 10.3390/jcm10112289.


Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy.

Dziewiecka E, Wisniowska-Smialek S, Karabinowska A, Holcman K, Gliniak M, Winiarczyk M J Clin Med. 2020; 9(6).

PMID: 32492830 PMC: 7355437. DOI: 10.3390/jcm9061660.